Flavia Scoyni

Flavia Scoyni

Auto-generated profile, based on publicly available information

Flavia Scoyni

Neuroinflammation research group, Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Stem Cell Reports
Verified
Journal Article
Open access
HKHenna Konttinen
Henna Konttinen
MCMauricio Castro Cabral-da-Silva
Mauricio Castro Cabral-da-Silva
SOSohvi Ohtonen
Sohvi Ohtonen
SWSara Wojciechowski
Sara Wojciechowski
ASAnastasia Shakirzyanova
Anastasia Shakirzyanova
TMTarja Malm
Tarja Malm
Here we elucidate the effect of Alzheimer disease (AD)-predisposing genetic backgrounds, APOE4, PSEN1ΔE9, and APPswe, on functionality of human microglia-like cells (iMGLs). We present a physiologically relevant high-yield protocol for producing iMGLs from induced pluripotent stem cells. Differentiation is directed with small molecules through primitive erythromyeloid progenitors to re-create microglial ontogeny from yolk sac. The iMGLs express microglial signature genes and respond to ADP with intracellular Ca2+ release distinguishing them from macrophages. Using 16 iPSC lines from healthy donors, AD patients and isogenic controls, we reveal that the APOE4 genotype has a profound impact on several aspects of microglial functionality, whereas PSEN1ΔE9 and APPswe mutations trigger minor alterations. The APOE4 genotype impairs phagocytosis, migration, and metabolic activity of iMGLs but exacerbates their cytokine secretion. This indicates that APOE4 iMGLs are fundamentally unable to mount normal microglial functionality in AD.

25 September 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Francesco RussoFrancesco Russo
Francesco Russo
SBSebastiano Di Bella
Sebastiano Di Bella
FVFederica Vannini
Federica Vannini
GBGabriele Berti
Gabriele Berti
FSFlavia Scoyni
Flavia Scoyni
AFAlfredo Ferro
Alfredo Ferro
MiRandola (http://mirandola.iit.cnr.it/) is a database of extracellular non-coding RNAs (ncRNAs) that was initially published in 2012, foreseeing the relevance of ncRNAs as non-invasive biomarkers. An increasing amount of experimental evidence shows that ncRNAs are frequently dysregulated in diseases. Further, ncRNAs have been discovered in different extracellular forms, such as exosomes, which circulate in human body fluids. Thus, miRandola 2017 is an effort to update and collect the accumulating information on extracellular ncRNAs that is spread across scientific publications and different databases. Data are manually curated from 314 articles that describe miRNAs, long non-coding RNAs and circular RNAs. Fourteen organisms are now included in the database, and associations of ncRNAs with 25 drugs, 47 sample types and 197 diseases. miRandola also classifies extracellular RNAs based on their extracellular form: Argonaute2 protein, exosome, microvesicle, microparticle, membrane vesicle, high density lipoprotein and circulating. We also implemented a new web interface to improve the user experience.

19 June 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
NKNatalia Kolosowska
Natalia Kolosowska
MGMaria Gotkiewicz
Maria Gotkiewicz
HDHiramani Dhungana
Hiramani Dhungana
LGLuca Giudice
Luca Giudice
RGRosalba Giugno
Rosalba Giugno
TMTarja Malm
Tarja Malm
Background: Ischemic stroke is a devastating disease without a cure. The available treatments for ischemic stroke, thrombolysis by tissue plasminogen activator, and thrombectomy are suitable only to a fraction of patients and thus novel therapeutic approaches are urgently needed. The neuroinflammatory responses elicited secondary to the ischemic attack further aggravate the stroke-induced neuronal damage. It has been demonstrated that these responses are regulated at the level of non-coding RNAs, especially miRNAs. Methods: We utilized lentiviral vectors to overexpress miR-669c in BV2 microglial cells in order to modulate their polarization. To detect whether the modulation of microglial activation by miR-669c provides protection in a mouse model of transient focal ischemic stroke, miR-669c overexpression was driven by a lentiviral vector injected into the striatum prior to induction of ischemic stroke. Results: Here, we demonstrate that miR-669c-3p, a member of chromosome 2 miRNA cluster (C2MC), is induced upon hypoxic and excitotoxic conditions in vitro and in two different in vivo models of stroke. Rather than directly regulating the neuronal survival in vitro, miR-669c is capable of attenuating the microglial proinflammatory activation in vitro and inducing the expression of microglial alternative activation markers arginase 1 (Arg1), chitinase-like 3 (Ym1), and peroxisome proliferator-activated receptor gamma (PPAR-γ). Intracerebral overexpression of miR-669c significantly decreased the ischemia-induced cell death and ameliorated the stroke-induced neurological deficits both at 1 and 3 days post injury (dpi). Albeit miR-669c overexpression failed to alter the overall Iba1 protein immunoreactivity, it significantly elevated Arg1 levels in the ischemic brain and increased colocalization of Arg1 and Iba1. Moreover, miR-669c overexpression under cerebral ischemia influenced several morphological characteristics of Iba1 positive cells. We further demonstrate the myeloid differentiation primary response gene 88 (MyD88) transcript as a direct target for miR-669c-3p in vitro and show reduced levels of MyD88 in miR-669c overexpressing ischemic brains in vivo. Conclusions: Collectively, our data provide the evidence that miR-669c-3p is protective in a mouse model of ischemic stroke through enhancement of the alternative microglial/macrophage activation and inhibition of MyD88 signaling. Our results accentuate the importance of controlling miRNA-regulated responses for the therapeutic benefit in conditions of stroke and neuroinflammation.

5 March 2024 in Cell Reports
Verified
Journal Article
Open access
FSFlavia Scoyni
Flavia Scoyni
VSValeriia Sitnikova
Valeriia Sitnikova
LGLuca Giudice
Luca Giudice
PKPaula Korhonen
Paula Korhonen
DTDavide M. Trevisan
Davide M. Trevisan
TMTarja Malm
Tarja Malm
Brain functionality relies on finely tuned regulation of gene expression by networks of non-coding RNAs (ncRNAs) such as the one composed by the circular RNA ciRS-7 (also known as CDR1as), the microRNA miR-7, and the long ncRNA Cyrano. We describe ischemia-induced alterations in the ncRNA network both in vitro and in vivo and in transgenic mice lacking ciRS-7 or miR-7. Our data show that cortical neurons downregulate ciRS-7 and Cyrano and upregulate miR-7 expression during ischemia. Mice lacking ciRS-7 exhibit reduced lesion size and motor impairment, while the absence of miR-7 alone results in increased ischemia-induced neuronal death. Moreover, miR-7 levels in pyramidal excitatory neurons regulate neurite morphology and glutamatergic signaling, suggesting a potential molecular link to the in vivo phenotype. Our data reveal the role of ciRS-7 and miR-7 in modulating ischemic stroke outcome, shedding light on the pathophysiological function of intracellular ncRNA networks in the brain.

12 October 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
FSFlavia Scoyni
Flavia Scoyni
LGLuca Giudice
Luca Giudice
MVMari‐Anna Väänänen
Mari‐Anna Väänänen
NDNicholas Downes
Nicholas Downes
PKPaula Korhonen
Paula Korhonen
TMTarja Malm
Tarja Malm
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disease and the main cause of dementia in the elderly. AD pathology is characterized by accumulation of microglia around the beta‐amyloid (Aβ) plaques which assumes disease‐specific transcriptional signatures, as for the disease‐associated microglia (DAM). However, the regulators of microglial phagocytosis are still unknown.METHODS: We isolated Aβ‐laden microglia from the brain of 5xFAD mice for RNA sequencing to characterize the transcriptional signature in phagocytic microglia and to identify the key non‐coding RNAs capable of regulating microglial phagocytosis. Through spatial sequencing, we show the transcriptional changes of microglia in the AD mouse brain in relation to Aβ proximity.RESULTS: Finally, we show that phagocytic messenger RNAs are regulated by miR‐7a‐5p, miR‐29a‐3p and miR‐146a‐5p microRNAs and segregate the DAM population into phagocytic and non‐phagocytic states.DISCUSSION: Our study pinpoints key regulators of microglial Aβ clearing capacity suggesting new targets for future therapeutic approaches.

1 January 2016
Verified
Book Chapter
Closed access
Francesco RussoFrancesco Russo
Francesco Russo
FSFlavia Scoyni
Flavia Scoyni
Alessandro FaticaAlessandro Fatica
Alessandro Fatica
MPMarco Pellegrini
Marco Pellegrini
AFAlfredo Ferro
Alfredo Ferro
Rosalba GiugnoRosalba Giugno
Rosalba Giugno